These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 22864111)

  • 1. Metformin targets ovarian cancer stem cells in vitro and in vivo.
    Shank JJ; Yang K; Ghannam J; Cabrera L; Johnston CJ; Reynolds RK; Buckanovich RJ
    Gynecol Oncol; 2012 Nov; 127(2):390-7. PubMed ID: 22864111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
    Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.
    Whitworth JM; Londoño-Joshi AI; Sellers JC; Oliver PJ; Muccio DD; Atigadda VR; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2012 Apr; 125(1):226-30. PubMed ID: 22155260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.
    Skubitz AP; Taras EP; Boylan KL; Waldron NN; Oh S; Panoskaltsis-Mortari A; Vallera DA
    Gynecol Oncol; 2013 Sep; 130(3):579-87. PubMed ID: 23721800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2.
    Choi YJ; Ingram PN; Yang K; Coffman L; Iyengar M; Bai S; Thomas DG; Yoon E; Buckanovich RJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):E6882-8. PubMed ID: 26621735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.
    Rattan R; Graham RP; Maguire JL; Giri S; Shridhar V
    Neoplasia; 2011 May; 13(5):483-91. PubMed ID: 21532889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
    Muñoz-Galván S; Felipe-Abrio B; Verdugo-Sivianes EM; Perez M; Jiménez-García MP; Suarez-Martinez E; Estevez-Garcia P; Carnero A
    Mol Cancer; 2020 Jan; 19(1):7. PubMed ID: 31926547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
    Komura N; Mabuchi S; Shimura K; Yokoi E; Kozasa K; Kuroda H; Takahashi R; Sasano T; Kawano M; Matsumoto Y; Kodama M; Hashimoto K; Sawada K; Kimura T
    Cancer Immunol Immunother; 2020 Dec; 69(12):2477-2499. PubMed ID: 32561967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer.
    Honjo S; Ajani JA; Scott AW; Chen Q; Skinner HD; Stroehlein J; Johnson RL; Song S
    Int J Oncol; 2014 Aug; 45(2):567-74. PubMed ID: 24859412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment.
    Wang L; Li X; Mu Y; Lu C; Tang S; Lu K; Qiu X; Wei A; Cheng Y; Wei W
    J Trace Elem Med Biol; 2019 Dec; 56():131-138. PubMed ID: 31466045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
    Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
    Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
    Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
    Lengyel E; Litchfield LM; Mitra AK; Nieman KM; Mukherjee A; Zhang Y; Johnson A; Bradaric M; Lee W; Romero IL
    Am J Obstet Gynecol; 2015 Apr; 212(4):479.e1-479.e10. PubMed ID: 25446664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin targets gastric cancer stem cells.
    Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
    Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.